APUS vs PLUG
Apimeds Pharmaceuticals US, Inc. (APUS) versus Plug Power Inc (PLUG) — a side-by-side from cached financials, not a winner call.
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.
Plug Power Inc (PLUG) is a electrical equipment & parts company listed on NASDAQ.
APUS does not have a complete income-statement cache yet.
Latest reported PLUG revenue for 2024-12-31 was $628.8M. Net income was -$2.10B. Revenue was down 29.5% from 2023-12-31 to 2024-12-31. PLUG currently screens at market cap $3.70B.
APUS currently screens at market cap $2.4M. PLUG currently screens at market cap $3.70B.
Not investment advice. Open the APUS and PLUG stock pages for the full models.
Not investment advice.